Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by Catalystking519on Dec 02, 2017 2:16am
281 Views
Post# 27076949

Revenue

Revenue He revenue tetra is capable of generating right now is laughable,  namaste was doing over $1mil a month in sales sitting at $0.20 forever, isol did the same.  The real revenue starts coming when healthcare professionals are prescribing ppp001 and we get a DIN#, along with dronabinol gettin FDA approval state side amongst other products in the pipe line.  To think that RX generate the revenue to make us jump to $2.00+ land is laughable, same with the marketing excuse stfu!  Yeah let’s spend millions on marketing a product that might sell $50-100,000 worth monthly (generous). But I do think once we are prescribing ppp001 we will see a rise in princips sales.  This is a game and if you’re crying about marketing you’re playing it wrong.  This will get drug back down to .59 and a lot will panic sell along the way:  my bids placed at .63
<< Previous
Bullboard Posts
Next >>